Carisma Therapeutics Inc. (NASDAQ: CARM)
$0.4080
-0.0099 ( -1.95% ) 93.6K
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
Market Data
Open
$0.4080
Previous close
$0.4179
Volume
93.6K
Market cap
$16.70M
Day range
$0.4030 - $0.4600
52 week range
$0.3809 - $3.1600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 23 | Apr 10, 2024 |
4 | Insider transactions | 1 | Apr 01, 2024 |
3 | Insider transactions | 1 | Apr 01, 2024 |
8-k | 8K-related | 15 | Apr 01, 2024 |
10-k | Annual reports | 81 | Apr 01, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |